文献速递主动脉疾病

D-二聚体作为排除血管内动脉瘤修复术后持续性2型内漏患者瘤囊扩张工具的可能性

Potential of D-Dimer as a Tool to Rule Out Sac Expansion in Patients With Persistent Type 2 Endoleaks After Endovascular Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2024-12-19

本研究回顾性分析2007年6月至2021年1月择期EVAR术后持续性2型内漏患者109例,探讨年度随访中D-二聚体水平与瘤囊扩张的相关性。结果显示1年和2年随访时低D-二聚体水平与较低的瘤囊扩张风险相关,最佳截断值分别为5.4和5.3 µg/mL,阴性预测值分别为86.9%和93.8%。作者认为低D-二聚体水平可能排除瘤囊扩张,建议将D-二聚体监测作为节省资源的随访方法。

要点

  • 持续性2型内漏患者1年和2年随访时低D-二聚体水平与5年内瘤囊扩张风险降低相关(p=0.03和0.01)。
  • 1年和2年D-二聚体最佳截断值分别为5.4和5.3 µg/mL,阴性预测值分别为86.9%和93.8%。
  • 模拟方案对瘤囊稳定且D-二聚体低的患者省略影像检查,可能漏诊1例瘤囊扩张,但3年内可节省28次影像检查。

核心结论

  • 1年和2年随访时低D-二聚体水平可能排除持续性2型内漏患者的瘤囊扩张,提示D-二聚体监测可作为节省资源的随访方法。

研究设计与样本

  • 回顾性单中心研究,纳入2007年6月至2021年1月择期EVAR术后患者,持续性2型内漏定义为6个月和12个月增强CT均确认,孤立性2型内漏定义为12个月内无其他类型内漏。
  • 纳入标准包括随访>2年、1年时孤立性持续性2型内漏、5年内任何年度随访有D-二聚体数据;共纳入109例患者,288个时间点的D-二聚体数据。

主要发现

  • 中位随访49个月(IQR 31-60),观察到43例瘤囊扩张(定义为5年内扩张≥5 mm)。
  • 无瘤囊扩张且有1年和2年D-二聚体数据的患者(分别为77例和56例)中,较低D-二聚体水平与瘤囊扩张风险降低相关(p=0.03和0.01)。
  • 1年和2年D-二聚体最佳截断值分别为5.4和5.3 µg/mL(AUC=0.651和0.702),阴性预测值分别为86.9%和93.8%。
  • Cox回归分析证实,D-二聚体超过截断值与瘤囊扩张显著相关(p=0.042和p=0.038)。
  • 模拟方案对瘤囊稳定且D-二聚体低的患者省略影像检查,可能漏诊1例瘤囊扩张,但若应用于本组患者,3年内可节省28次影像检查。

关键数值与推荐

  • 1年D-二聚体截断值5.4 µg/mL(AUC=0.651),阴性预测值86.9%。
  • 2年D-二聚体截断值5.3 µg/mL(AUC=0.702),阴性预测值93.8%。

临床怎么用

  • 作者建议对持续性2型内漏患者进行D-二聚体监测,作为节省资源的随访方法。
  • 作者提出的模拟方案对瘤囊稳定且D-二聚体低的患者省略影像检查,可能漏诊1例瘤囊扩张,但3年内可节省28次影像检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In managing type 2 endoleak (T2EL) following endovascular aortic aneurysm repair (EVAR), an indication for reintervention is aneurysm enlargement (AnE). A previous study found that low D-dimer levels (DDLs) at 1 year were associated with reduced AnE risk in patients with persistent T2ELs (pT2ELs). This study analyzed patients with pT2ELs to determine the correlation between DDLs at annual follow-ups and AnE and proposed a follow-up protocol incorporating DDL monitoring. METHODS: A retrospective review of elective EVAR cases between June 2007 and January 2021 identified "persistent" T2EL as confirmed at both 6- and 12-month contrast-enhanced CT studies. "Isolated" T2EL referred to cases without other endoleak types within 12 months. Inclusion criteria comprised >2 years of follow-up, isolated pT2ELs at 1 year, and DDL data at any annual follow-up over 5 years. The association between DDL and AnE, defined as ≥5 mm expansion within 5 years, was analyzed. RESULTS: A total of 109 patients with DDL data at 288 time points were enrolled. During a median follow-up of 49 months [31-60, IQR], 43 AnE were observed. In patients without AnE and with DDL data at 1 and 2 years (N=77 and 56), lower DDLs were associated with a reduced AnE risk (p=0.03 and 0.01). Optimal cutoff points were 5.4 and 5.3 µg/mL (AUC=0.651 and 0.702) with high negative predictive values (86.9% and 93.8%). Cox regression analyses confirmed that DDLs surpassing the cutoff values correlated significantly with AnE (p=0.042 and p=0.038). Our simulated protocol for omitting imaging studies in patients with stable aneurysms and low DDL might have overlooked one AnE but could have saved 28 imaging studies over 3 years if implemented on our patients. CONCLUSION: Low DDLs at the 1- and 2-year follow-ups can potentially exclude AnE in pT2EL patients, suggesting DDL monitoring as a resource-saving approach.Clinical ImpactThe management of type 2 endoleaks in post-EVAR patients has been a topic of debate. This retrospective single-center study, featuring strict inclusion criteria, included 109 patients with persistent type 2 endoleaks. The findings indicate that patients with lower D-dimer levels at 1- and 2-year follow-ups are unlikely to experience sac enlargement ≥5 mm within 5 years, even in the presence of type 2 endoleaks. This study suggests that D-dimer monitoring has the potential to reduce reliance on imaging studies for the follow-up of patients with type 2 endoleaks, leading to significant savings in medical resources.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Sugimoto M, Lee C, Ikeda S, et al. Potential of D-Dimer as a Tool to Rule Out Sac Expansion in Patients With Persistent Type 2 Endoleaks After Endovascular Aneurysm Repair. J Endovasc Ther. 2024. PMID: 39698746. doi:10.1177/15266028241306277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。